Halozyme Therapeutics
HALO
YETI Holdings
YETI
eBay
EBAY
4
Workday
WDAY
5
Collegium Pharmaceutical
COLL
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -18.19%114.28M | -14.33%148.32M | -14.33%148.32M | 28.79%35M | 221.48%49.94M | 139.69%139.7M | 276.14%173.12M | 276.14%173.12M | 60.12%27.18M | -24.50%15.53M |
-Cash and cash equivalents | -18.19%114.28M | -14.33%148.32M | -14.33%148.32M | 28.79%35M | 221.48%49.94M | 139.69%139.7M | 276.14%173.12M | 276.14%173.12M | 60.12%27.18M | -24.50%15.53M |
Receivables | 16.20%405.61M | 10.36%390.1M | 10.36%390.1M | 5.12%387.43M | -2.63%363.32M | -1.49%349.05M | 2.62%353.49M | 2.62%353.49M | 17.27%368.58M | 24.67%373.12M |
-Accounts receivable | 14.01%357.76M | 9.06%339.37M | 9.06%339.37M | 5.22%337.72M | 2.49%326.58M | 0.77%313.79M | -3.03%311.17M | -3.03%311.17M | 13.21%320.97M | 16.59%318.65M |
-Taxes receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -39.72%393K | 2,336.08%7.7M |
-Other receivables | 35.69%47.84M | 19.88%50.74M | 19.88%50.74M | 5.29%49.71M | -21.44%36.74M | -15.98%35.26M | 79.43%42.32M | 79.43%42.32M | 56.73%47.21M | 82.30%46.77M |
Inventory | 1.56%109.88M | -0.67%103.11M | -0.67%103.11M | 4.41%109.79M | 2.41%107.48M | -1.11%108.19M | 2.38%103.81M | 2.38%103.81M | -19.91%105.15M | -12.32%104.95M |
Restricted cash | --0 | 0.00%91K | 0.00%91K | 0.00%91K | -1.10%90K | 0.00%91K | 0.00%91K | 0.00%91K | 0.00%91K | 0.00%91K |
Other current assets | 61.50%31.99M | 12.23%20.25M | 12.23%20.25M | 40.98%22.27M | 52.30%23.26M | 14.91%19.81M | -25.24%18.04M | -25.24%18.04M | 35.59%15.8M | 11.94%15.27M |
Total current assets | 7.28%661.76M | 2.05%661.87M | 2.05%661.87M | 7.31%554.58M | 6.90%544.1M | 14.37%616.83M | 25.66%648.55M | 25.66%648.55M | 8.96%516.79M | 12.28%508.97M |
Non current assets | ||||||||||
Net PPE | 33.85%157.26M | 16.11%128.13M | 16.11%128.13M | 16.05%121.55M | 17.07%118.93M | 17.36%117.48M | 6.75%110.35M | 6.75%110.35M | 4.00%104.74M | -5.84%101.59M |
-Gross PPE | 33.85%157.26M | 15.21%241.6M | 15.21%241.6M | 16.05%121.55M | 17.07%118.93M | 17.36%117.48M | 6.93%209.71M | 6.93%209.71M | 4.00%104.74M | -5.84%101.59M |
-Accumulated depreciation | ---- | -14.20%-113.47M | -14.20%-113.47M | ---- | ---- | ---- | -7.12%-99.36M | -7.12%-99.36M | ---- | ---- |
Goodwill and other intangible assets | 23.93%543.57M | 31.90%538.02M | 31.90%538.02M | 31.08%537.46M | 23.62%512.72M | 7.34%438.62M | -1.32%407.89M | -1.32%407.89M | -1.79%410.04M | -1.02%414.74M |
-Goodwill | 24.00%459.96M | 31.50%452.34M | 31.50%452.34M | 30.98%448.1M | 24.70%426.82M | 11.12%370.95M | 3.07%343.99M | 3.07%343.99M | 2.74%342.12M | 1.90%342.27M |
-Other intangible assets | 23.54%83.61M | 34.09%85.68M | 34.09%85.68M | 31.57%89.36M | 18.53%85.9M | -9.56%67.68M | -19.71%63.9M | -19.71%63.9M | -19.64%67.91M | -12.83%72.47M |
Other non current assets | 77.68%19.93M | 101.64%21.47M | 101.64%21.47M | 31.85%17.86M | 46.73%13.41M | 121.33%11.22M | 138.98%10.65M | 138.98%10.65M | 280.53%13.54M | 139.03%9.14M |
Total non current assets | 27.05%720.76M | 30.01%687.62M | 30.01%687.62M | 28.12%676.86M | 22.76%645.05M | 10.41%567.32M | 1.48%528.88M | 1.48%528.88M | 1.25%528.32M | -0.99%525.47M |
Total assets | 16.75%1.38B | 14.61%1.35B | 14.61%1.35B | 17.83%1.23B | 14.96%1.19B | 12.44%1.18B | 13.51%1.18B | 13.51%1.18B | 4.92%1.05B | 5.12%1.03B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | 17.44%114.3M | 7.52%103.73M | 7.52%103.73M | 5.29%106.8M | 7.67%101.19M | -13.56%97.32M | 3.95%96.47M | 3.95%96.47M | 2.95%101.44M | -10.55%93.98M |
-accounts payable | 17.44%114.3M | 7.52%103.73M | 7.52%103.73M | 5.29%106.8M | 7.67%101.19M | -8.46%97.32M | 3.95%96.47M | 3.95%96.47M | 3.57%101.44M | -9.32%93.98M |
Current accrued expenses | 24.26%39.33M | 14.93%41.65M | 14.93%41.65M | 16.01%41.23M | 15.49%32.99M | 18.93%31.66M | 38.00%36.24M | 38.00%36.24M | 29.45%35.54M | -0.65%28.56M |
Current debt and capital lease obligation | 8.95%23.2M | 2.76%21.52M | 2.76%21.52M | 3.03%20.43M | -4.49%20.72M | -3.49%21.3M | -6.74%20.94M | -6.74%20.94M | -67.72%19.83M | -57.47%21.69M |
-Current debt | 19.91%6.6M | 19.91%6.6M | 19.91%6.6M | 25.89%5.5M | 25.89%5.5M | 25.89%5.5M | 25.89%5.5M | 25.89%5.5M | -90.05%4.37M | -86.53%4.37M |
-Current capital lease obligation | 5.14%16.61M | -3.35%14.92M | -3.35%14.92M | -3.43%14.93M | -12.16%15.22M | -10.75%15.8M | -14.63%15.44M | -14.63%15.44M | -11.79%15.46M | -6.77%17.32M |
Current deferred liabilities | 59.78%33.26M | 21.47%26.32M | 21.47%26.32M | 24.23%24.57M | 21.44%25.37M | -15.70%20.81M | -29.05%21.67M | -29.05%21.67M | -33.55%19.78M | 6.89%20.89M |
Other current liabilities | -39.43%35.32M | 3.93%50.77M | 3.93%50.77M | 24.43%56.34M | 10.75%47.45M | 50.31%58.31M | 19.61%48.85M | 19.61%48.85M | 57.87%45.28M | 28.53%42.84M |
Current liabilities | 6.98%245.42M | 8.84%243.98M | 8.84%243.98M | 12.40%249.36M | 9.49%227.7M | 2.07%229.4M | 5.29%224.17M | 5.29%224.17M | -9.76%221.86M | -12.51%207.97M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | 19.02%665.48M | 17.98%654.84M | 17.98%654.84M | 25.34%554.17M | 24.72%556.35M | 25.01%559.13M | 23.51%555.03M | 23.51%555.03M | 25.96%442.13M | 25.72%446.08M |
-Long term debt | 19.35%620.9M | 19.39%621.68M | 19.39%621.68M | 27.23%519.25M | 27.25%519.74M | 27.27%520.22M | 27.25%520.7M | 27.25%520.7M | 30.08%408.11M | 29.80%408.43M |
-Long term capital lease obligation | 14.57%44.58M | -3.43%33.16M | -3.43%33.16M | 2.63%34.92M | -2.74%36.62M | 1.06%38.91M | -14.56%34.34M | -14.56%34.34M | -8.72%34.03M | -6.26%37.65M |
Non current deferred liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -76.89%2.07M | -81.66%2.21M |
Other non current liabilities | 33.70%26.95M | 60.60%27.88M | 60.60%27.88M | 65.12%25.54M | 134.11%20.41M | 322.60%20.16M | 80.95%17.36M | 80.95%17.36M | 233.60%15.47M | 123.94%8.72M |
Total non current liabilities | 19.53%692.44M | 19.28%682.72M | 19.28%682.72M | 26.12%579.71M | 26.21%576.76M | 27.56%579.29M | 24.71%572.39M | 24.71%572.39M | 26.07%459.67M | 23.27%457M |
Total liabilities | 15.97%937.85M | 16.34%926.71M | 16.34%926.71M | 21.65%829.08M | 20.98%804.47M | 19.12%808.69M | 18.56%796.56M | 18.56%796.56M | 11.64%681.53M | 9.29%664.97M |
Shareholders'equity | ||||||||||
Share capital | -39.06%220K | -39.06%220K | -39.06%220K | 0.00%361K | 0.00%361K | 0.00%361K | 0.00%361K | 0.00%361K | 0.00%361K | 69.48%361K |
-common stock | -40.87%204K | -40.87%204K | -40.87%204K | 0.00%345K | 0.00%345K | 0.00%345K | 0.00%345K | 0.00%345K | 0.00%345K | 75.13%345K |
-Preferred stock | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K | 0.00%16K |
Retained earnings | 24.10%410.24M | 22.05%389.67M | 22.05%389.67M | 21.45%368.33M | 20.94%347.25M | 23.30%330.58M | 27.43%319.27M | 27.43%319.27M | 24.59%303.29M | 25.11%287.14M |
Paid-in capital | 1.57%220.7M | 1.40%219.51M | 1.40%219.51M | 1.10%218.06M | 0.91%216.8M | 1.39%217.29M | 1.19%216.48M | 1.19%216.48M | 1.04%215.68M | 1.30%214.85M |
Less: Treasury stock | 8.56%152.98M | 23.39%153M | 23.39%153M | 23.39%153M | 45.12%147.97M | 83.21%140.92M | 82.94%124M | 82.94%124M | 223.08%124M | 191.14%101.97M |
Gains losses not affecting retained earnings | -5.24%-33.52M | -7.59%-33.61M | -7.59%-33.61M | 1.20%-31.38M | -2.73%-31.76M | -0.88%-31.85M | 1.37%-31.24M | 1.37%-31.24M | 1.85%-31.76M | 0.92%-30.92M |
Total stockholders'equity | 18.43%444.66M | 11.00%422.79M | 11.00%422.79M | 10.67%402.37M | 4.12%384.68M | 0.32%375.46M | 4.24%380.88M | 4.24%380.88M | -5.93%363.58M | -1.63%369.47M |
Total equity | 18.43%444.66M | 11.00%422.79M | 11.00%422.79M | 10.67%402.37M | 4.12%384.68M | 0.32%375.46M | 4.24%380.88M | 4.24%380.88M | -5.71%363.58M | -1.63%369.47M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |